FR3045408B1 - Assemblages de nanoparticules hydrophobes en milieu aqueux - Google Patents

Assemblages de nanoparticules hydrophobes en milieu aqueux Download PDF

Info

Publication number
FR3045408B1
FR3045408B1 FR1562860A FR1562860A FR3045408B1 FR 3045408 B1 FR3045408 B1 FR 3045408B1 FR 1562860 A FR1562860 A FR 1562860A FR 1562860 A FR1562860 A FR 1562860A FR 3045408 B1 FR3045408 B1 FR 3045408B1
Authority
FR
France
Prior art keywords
assemblies
aqueous medium
hydrophobic nanoparticles
present
hybridosomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1562860A
Other languages
English (en)
Other versions
FR3045408A1 (fr
Inventor
Fabienne Gauffre
Flavien Sciortino
Gerald Casterou
Myrtil Kahn
Soizic Chevance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite De Rennes Fr
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Rennes 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Rennes 1 filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1562860A priority Critical patent/FR3045408B1/fr
Priority to PCT/FR2016/053522 priority patent/WO2017103534A2/fr
Publication of FR3045408A1 publication Critical patent/FR3045408A1/fr
Application granted granted Critical
Publication of FR3045408B1 publication Critical patent/FR3045408B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
    • B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

La présente invention se situe dans le domaine des nanomatériaux. Plus particulièrement, la présente invention concerne de nouveaux nano-objets, les hybridosomes, constitués d'un cœur aqueux et d'une coque hybride organique-inorganique. Celle-ci comprend à la fois des nanoparticules inorganiques et des chaînes de polymère. La présente invention concerne également un procédé de préparation de ces hybridosomes et leurs utilisations.
FR1562860A 2015-12-18 2015-12-18 Assemblages de nanoparticules hydrophobes en milieu aqueux Active FR3045408B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1562860A FR3045408B1 (fr) 2015-12-18 2015-12-18 Assemblages de nanoparticules hydrophobes en milieu aqueux
PCT/FR2016/053522 WO2017103534A2 (fr) 2015-12-18 2016-12-16 Assemblages de nanoparticules hydrophobes en milieu aqueux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1562860A FR3045408B1 (fr) 2015-12-18 2015-12-18 Assemblages de nanoparticules hydrophobes en milieu aqueux

Publications (2)

Publication Number Publication Date
FR3045408A1 FR3045408A1 (fr) 2017-06-23
FR3045408B1 true FR3045408B1 (fr) 2021-01-08

Family

ID=55646765

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1562860A Active FR3045408B1 (fr) 2015-12-18 2015-12-18 Assemblages de nanoparticules hydrophobes en milieu aqueux

Country Status (2)

Country Link
FR (1) FR3045408B1 (fr)
WO (1) WO2017103534A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110591361B (zh) * 2019-10-16 2020-09-25 中国科学院兰州化学物理研究所 一种杂化自润滑微胶囊及其制备方法、自润滑复合材料及其制备方法
CN110964510A (zh) * 2019-11-14 2020-04-07 上海大学 一种磁性/上转换发光水溶性纳米材料、制备方法及其应用
CN113203724B (zh) * 2021-04-28 2024-01-26 太原理工大学 一种单层密排纳米颗粒孔阵列结构及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5463549B2 (ja) * 2009-09-08 2014-04-09 学校法人福岡大学 超音波治療用リポソーム及び超音波治療促進用リポソーム
EP2575896A2 (fr) * 2010-05-26 2013-04-10 Erik Reimhult Structures de membranes réactives aux champs magnétiques

Also Published As

Publication number Publication date
WO2017103534A3 (fr) 2017-10-12
WO2017103534A2 (fr) 2017-06-22
FR3045408A1 (fr) 2017-06-23

Similar Documents

Publication Publication Date Title
AR113031A1 (es) Composiciones de nanopartículas lipídicas (lnp) que comprende arn
FR3045408B1 (fr) Assemblages de nanoparticules hydrophobes en milieu aqueux
BR112017018832A2 (pt) profármacos de riluzol e seu uso
CY1120523T1 (el) Συνδυαστικη θεραπεια με υαλουρονιδαση και στοχευμενο προς τον ογκο ταξανιο
MA38341A1 (fr) Modulateurs d'enzymes de modification par méthylation, compositions et utilisations associées
TN2010000154A1 (fr) Composition destinee a la regulation du metabolism des lipides
MX340055B (es) Metodos y composiciones de nanoparticulas sin priones.
BR112012021775A2 (pt) processo para fabricação de um laminado de filme/não tecido
BR112015022861A8 (pt) inibidores de bromodomínio
BR112015011118A2 (pt) conjugado; composição farmacêutica; e uso de um ou mais dos conjugados
WO2017112826A3 (fr) Conjugués polymères ayant une antigénicité réduite et leurs procédés d'utilisation
WO2010042638A3 (fr) Conjugués hpma-docétaxel ou gemcitabine et utilisations associées
MA38814B2 (fr) Agoniste gitr et antagoniste pd-1 pour leurs utilisations dans le traitement de troubles proliferatifs
MA38175A1 (fr) Lactames fusionnés à un aryle et hétéroaryle
EA201290498A1 (ru) Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
BR112017016093A2 (pt) composição sólida, curativo de ferida, e, método de fabricação de uma composição
BR112017016100A2 (pt) composição, curativo de ferida, e, método de fabricação de uma composição.
CL2015002210A1 (es) Conjugados de ciclosporina a y esteroide
BRPI0720991A8 (pt) Preparação da romidepsina
BR112015001414A2 (pt) composição antideriva
MA39200A1 (fr) Procédé de fabrication d'une solution injectable stable de noradrénaline à faible concentration
WO2012011693A3 (fr) Lipide cationique, son procédé de production, et véhicule possédant des propriétés de pénétration cellulaire le comprenant
MX2021012894A (es) Compuestos ciclicos de fosfato.
CL2012000241A1 (es) Composición para disminuir el material particulado en suspensión en aire o un líquido que comprende una fuente de exopolisacáridos (eps), una cepa de microorganismos con actividad ureolítica y medio de cultivo; método para disminuir material particulado en suspensión en aire o un líquido que comprende aplicar dicha composición.
BR112012033806A2 (pt) composição na forma de uma partícula, método para sua preparação e uso da composição

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170623

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

TQ Partial transmission of property

Owner name: UNIVERSITE DE RENNES, FR

Effective date: 20231128

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20231128